We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03313778
Brief Title: Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors (KEYNOTE-603)

First Submitted : October 13, 2017
First Submitted that Met QC Criteria : October 13, 2017
First Posted : October 18, 2017

Last Update Submitted that Met QC Criteria : September 20, 2022
Last Update Posted : September 22, 2022